Skip to main content

How an open-science advocate aims to shake up pharma

By April 28, 2016News
dana-farber-cancer-logo

dana-farber-cancer-logo

Dr. Jay Bradner, a decorated cancer researcher from the Dana-Farber Cancer Institute, turned heads last year when he accepted a top job at Novartis, one of the world’s largest drug makers. Academics jump to industry all the time, but Bradner made his name with a move pharma almost never makes: When he discovered a potentially cancer-fighting molecule, he just gave it away.

{iframe}https://www.statnews.com/2016/04/26/jay-bradner-novartis-cancer/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.